摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,21-dihydrorhazinilam N-oxide

中文名称
——
中文别名
——
英文名称
5,21-dihydrorhazinilam N-oxide
英文别名
(12R,19R)-12-ethyl-16-oxido-8-aza-16-azoniatetracyclo[10.6.1.02,7.016,19]nonadeca-1(18),2,4,6-tetraen-9-one
5,21-dihydrorhazinilam N-oxide化学式
CAS
——
化学式
C19H24N2O2
mdl
——
分子量
312.412
InChiKey
LYHAEQZONMBWFL-KTVLMBSMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    47.2
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,21-dihydrorhazinilam N-oxide氧气 、 iron(II) sulfate 作用下, 生成 rhazinilam
    参考文献:
    名称:
    Hemisynthesis of rhazinilam analogues: structure - activity relationships on tubulin-microtubule system
    摘要:
    Semi-synthesis of derivatives of rhazinilam, an antitubulin compound, delineated some molecular features necessary for biological activity. In the course of this study, the formation of rhazinilam from 1,2-didehydroaspidospermidine is reexamined and a new mechanism is proposed. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(97)00391-0
  • 作为产物:
    描述:
    eburenine碳酸氢钠间氯过氧苯甲酸 作用下, 以 二氯甲烷 为溶剂, 以65%的产率得到5,21-dihydrorhazinilam N-oxide
    参考文献:
    名称:
    D-ring substituted rhazinilam analogues: semisynthesis and evaluation of antitubulin activity
    摘要:
    Novel (-)- and (+)-rhazinilam derivatives substituted on the D-ring (compounds 3, 4, 5 and 6) have been prepared from (+)-vincadifformine 7 and (-)-tabersonine and evaluated against the disassembly of microtubules into tubulin. Along with this study, a reproducible 'one pot' semisynthesis of (-)-rhazinilam 1 from (+)-1,2-didehydroaspidospermidine 2 was performed allowing the easy preparation of these new compounds. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(99)00241-2
点击查看最新优质反应信息

文献信息

  • Hemisynthesis of rhazinilam analogues: structure - activity relationships on tubulin-microtubule system
    作者:Bruno David、Thierry Sévenet、Odile Thoison、Khalijah Awang、Mary Païs、Michel Wright、Daniel Guénard
    DOI:10.1016/s0960-894x(97)00391-0
    日期:1997.9
    Semi-synthesis of derivatives of rhazinilam, an antitubulin compound, delineated some molecular features necessary for biological activity. In the course of this study, the formation of rhazinilam from 1,2-didehydroaspidospermidine is reexamined and a new mechanism is proposed. (C) 1997 Elsevier Science Ltd.
  • D-ring substituted rhazinilam analogues: semisynthesis and evaluation of antitubulin activity
    作者:Christophe Dupont、Daniel Guénard、Luba Tchertanov、Sylviane Thoret、Françoise Guéritte
    DOI:10.1016/s0968-0896(99)00241-2
    日期:1999.12
    Novel (-)- and (+)-rhazinilam derivatives substituted on the D-ring (compounds 3, 4, 5 and 6) have been prepared from (+)-vincadifformine 7 and (-)-tabersonine and evaluated against the disassembly of microtubules into tubulin. Along with this study, a reproducible 'one pot' semisynthesis of (-)-rhazinilam 1 from (+)-1,2-didehydroaspidospermidine 2 was performed allowing the easy preparation of these new compounds. (C) 1999 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

Leuconolam; (8aR,12aS,14bS)-8a-乙基-7,8,8a,10,11,12a-六氢-12a-羟基吲嗪并[8,1-ef][1]苯并乌头原碱-6,13(5H,9H)-二酮 (-)-Melodinine E 5,21-dihydrorhazinilam N-oxide 5,21-dihydrorhazinilam (-)-leuconoxine leuconolam (-)-scholarisine G melodinine E epileuconolam β-chlorodiazaspiroleuconolam α-chlorodiazaspiroleuconolam O-methylleuconolam 6β,7β-dibromodiazaspiroleuconolam (-)-leuconolam 15-Ethyl-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2,4,6-triene-9,10,18-trione 12-Ethyl-8,16-diazatetracyclo[10.6.1.02,7.016,19]nonadeca-2,4,6,17-tetraen-9-one 12-Ethyl-19-methoxy-8,16-diazatetracyclo[10.6.1.02,7.016,19]nonadeca-1(18),2,4,6-tetraene-9,17-dione 15-Ethyl-5-hydroxy-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2(7),3,5-triene-10,18-dione 15-Ethyl-8-hydroxy-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2,4,6-triene-10,18-dione 15-Ethyl-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2,4,6,8-tetraene-10,18-dione 15-Ethyl-9-hydroxy-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2,4,6-triene-10,18-dione 12-Ethyl-19-hydroxy-8,16-diazatetracyclo[10.6.1.02,7.016,19]nonadeca-1(18),2,4,6,14-pentaene-9,17-dione 15-Ethyl-8-hydroxy-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2,4,6-trien-18-one 15-Ethyl-5-(15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-yl)-8-methoxy-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2(7),3,5-trien-4-ol 15-Ethyl-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2,4,6-trien-18-one 12-Ethyl-8,16-diazatetracyclo[10.6.1.02,7.016,19]nonadeca-1(18),2,4,6-tetraen-9-one 15-Ethyl-1,11-diazapentacyclo[9.7.1.02,7.08,19.015,19]nonadeca-2,4,6-triene-10,18-dione